Metformin and/or clomiphene do not adversely affect liver or renal function in women with polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 10, 2011, Pages

  Aubuchon, Mira ^a   Kunselman, Allen R ^b   Schlaff, William D ^c   Diamond, Michael P ^e   Coutifaris, Christos ^h   Carson, Sandra A ^e,f,n   Steinkampf, Michael P ^g,o   Carr, Bruce R ^d   McGovern, Peter G ⁱ   Cataldo, Nicholas A ^j   Gosman, Gabriella G ^k   Nestler, John E ^l   Myers, Evan R ^m   Legro, Richard S ^b  

^a University of Missouri   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^j STANFORD UNIVERSITY   (United States)

^k UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^l VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ WOMEN AND INFANTS HOSPITAL   (United States)

^o Women and Infant's Hospital ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CLOMIFENE CITRATE; CREATININE; METFORMIN;

ARTICLE; CREATININE BLOOD LEVEL; DRUG RESPONSE; FEMALE; HUMAN; KIDNEY FUNCTION; LIVER FUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; CLOMIPHENE; DOUBLE-BLIND METHOD; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFERTILITY, FEMALE; KIDNEY; KIDNEY FUNCTION TESTS; LIVER; LIVER FUNCTION TESTS; METFORMIN; POLYCYSTIC OVARY SYNDROME;

EID: 80053555121     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1093     Document Type: Article

References (17)

1. Legro RS, Myers ER, Barnhart HX, Carson SA, Diamond MP, Carr BR, Schlaff WD, Coutifaris C, McGovern PG, Cataldo NA, Steinkampf MP, Nestler JE, Gosman G, Guidice LC, Leppert PC 2006 The pregnancy in polycystic ovary syndrome study: baseline characteristics of the randomized cohort including racial effects. Fertil Steril 86:914-933 (Pubitemid 44485050)
2. Babich MM, Pike I, Shiffman ML 1998 Metformin-induced acute hepatitis. Am J Med 104:490-492 (Pubitemid 28274855)
3. Deutsch M, Kountouras D, Dourakis SP 2004 Metformin hepatotoxicity. Ann Intern Med 140:W25
4. Kutoh E 2005 Possible metformin-induced hepatotoxicity. Am J Geriatr Pharmacother 3:270-273 (Pubitemid 43264605)
5. Krakoff J, Clark JM, Crandall JP, Wilson C, Molitch ME, Brancati FL, Edelstein SL, Knowler WC 2010 Effects of metformin and weight loss on serum alanine aminotransferase activity in the diabetes prevention program. Obesity (Silver Spring) 18:1762-1767
6. Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, Steinkampf MP, Coutifaris C, McGovern PG, Cataldo NA, Gosman GG, Nestler JE, Giudice LC, Leppert PC, Myers ER 2007 Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 356:551-566 (Pubitemid 46220816)
7. Huber PJ 1973 Robust regression: asymptotics, conjectures and Monte Carlo. Ann Stat 1:799-821
8. Preiss D, Sattar N, Harborne L, Norman J, Fleming R 2008 The effects of 8 months of metformin on circulatingGGTand ALT levels in obese women with polycystic ovarian syndrome. Int J Clin Pract 62:1337-1343
9. Straznicky NE, Grima MT, Lambert EA, Eikelis N, Dawood T, Lambert GW, Nestel PJ, Masuo K, Sari CI, Chopra R, Mariani JA, Schlaich MP 2011 Exercise augments weight loss induced improvement in renal function in obese metabolic syndrome individuals. J Hypertens 29:553-564
10. Cerda C, Pérez-Ayuso RM, Riquelme A, Soza A, Villaseca P, Sir- Petermann T, Espinoza M, Pizarro M, Solis N, Miquel JF, ArreseM 2007 Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. J Hepatol 47:412-417 (Pubitemid 47176161)
11. Setji TL, Holland ND, Sanders LL, Pereira KC, Diehl AM, Brown AJ 2006 Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 91:1741-1747
12. Garinis GA, Fruci B, Mazza A, De Siena M, Abenavoli S, Gulletta E, Ventura V, Greco M, Abenavoli L, Belfiore A 2010 Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study. Int J Obes (Lond) 34:1255-1264
13. Chen MJ, Chiu HM, Chen CL, Yang WS, Yang YS, Ho HN 2010 Hyperandrogenemia is independently associated with elevated alanine aminotransferase activity in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 95:3332-3341
14. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM 2002 Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403 (Pubitemid 34437694)
15. Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, Fowler S 2005 The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med 142:611-619 (Pubitemid 40529957)
16. Duseja A, Das A, Dhiman RK, Chawla YK, Thumburu KT, Bhadada S, Bhansali A 2007 Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions. Ann Hepatol 6:222-226
17. Rausch ME, Legro RS, Barnhart HX, Schlaff WD, Carr BR, DiamondMP, Carson SA, SteinkampfMP,McGovernPG, CataldoNA, Gosman GG, Nestler JE, Giudice LC, Leppert PC, Myers ER, Coutifaris C 2009 Predictors of pregnancy in women with polycystic ovary syndrome. J Clin Endocrinol Metab 94:3458-3466